Revenue grew 16.1% to $150 million, with strong U.S. and Rest of World sales and nearly doubled NovoSorb MTX sales. Expanded manufacturing, new product launches, and a strengthened sales team position the company for continued growth in FY27.Original document: Polynovo Limited [PNV] Earnings Releas…
Revenue grew 16.1% to $150 million, with strong U.S. and Rest of World sales and nearly doubled NovoSorb MTX sales. Expanded manufacturing, new product launches, and a strengthened sales team position the company for continued growth in FY27.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.
